259 related articles for article (PubMed ID: 26403783)
1. Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers.
Mezache L; Paniccia B; Nyinawabera A; Nuovo GJ
Mod Pathol; 2015 Dec; 28(12):1594-602. PubMed ID: 26403783
[TBL] [Abstract][Full Text] [Related]
2. Comparison of programmed death-ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer.
Hosseini MS; Shafizadeh F; Bahremani MH; Farzaneh F; Ashrafganjoei T; Arab M; Talayeh M; Jafari F; Abdshah A
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2057. PubMed ID: 38662366
[TBL] [Abstract][Full Text] [Related]
3. Programmed death-ligand 1 (PD-L1) expression in cervical intraepithelial neoplasia and cervical squamous cell carcinoma of HIV-infected and non-infected patients.
Brito MJ; Sequeira P; Quintas A; Silva I; Silva F; Martins C; Félix A
Virchows Arch; 2024 Mar; 484(3):507-516. PubMed ID: 37341812
[TBL] [Abstract][Full Text] [Related]
4. The distribution of novel biomarkers in carcinoma-in-situ, microinvasive, and squamous cell carcinoma of the uterine cervix.
Nicol AF; de Andrade CV; Gomes SC; Brusadelli MG; Lodin HM; Wells SI; Nuovo GJ
Ann Diagn Pathol; 2019 Feb; 38():115-122. PubMed ID: 30579259
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV.
Lovane L; Tulsidás S; Carrilho C; Karlsson C
Sci Rep; 2024 Jun; 14(1):12974. PubMed ID: 38839923
[TBL] [Abstract][Full Text] [Related]
6. Modulation of sHLA-G, PD-1, and PD-L1 Expression in Cervical Lesions Following Imiquimod Treatment and Its Association with Treatment Success.
Cokan A; da Silva NCH; Kavalar R; But I; Pakiž M; Andrade de Oliveira S; Dos Santos Gomes FO; da Silva RS; Peixoto CA; Lucena-Silva N
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610950
[TBL] [Abstract][Full Text] [Related]
7. Targeting cervical cancer with anti-PD-1 antibodies: what is new?
Greenman M; McNamara B; Mutlu L; Santin AD
Expert Opin Biol Ther; 2024 Mar; 24(3):111-114. PubMed ID: 38391293
[No Abstract] [Full Text] [Related]
8. ADORA2B facilitates cervical carcinoma progression by maintaining PD-L1 expression through master regulator CMTM6.
Ma H; Shi S; Ma Z; Niu S; Liu X; Sun J; Zhang Z; Liu H
Panminerva Med; 2024 Apr; ():. PubMed ID: 38625046
[No Abstract] [Full Text] [Related]
9. Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.
Heeren AM; Punt S; Bleeker MC; Gaarenstroom KN; van der Velden J; Kenter GG; de Gruijl TD; Jordanova ES
Mod Pathol; 2016 Jul; 29(7):753-63. PubMed ID: 27056074
[TBL] [Abstract][Full Text] [Related]
10. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.
Howitt BE; Sun HH; Roemer MG; Kelley A; Chapuy B; Aviki E; Pak C; Connelly C; Gjini E; Shi Y; Lee L; Viswanathan A; Horowitz N; Neuberg D; Crum CP; Lindeman NL; Kuo F; Ligon AH; Freeman GJ; Hodi FS; Shipp MA; Rodig SJ
JAMA Oncol; 2016 Apr; 2(4):518-22. PubMed ID: 26913631
[TBL] [Abstract][Full Text] [Related]
11. Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
Kim HS; Lee JY; Lim SH; Park K; Sun JM; Ko YH; Baek CH; Son YI; Jeong HS; Ahn YC; Lee MY; Hong M; Ahn MJ
Cancer Res Treat; 2016 Apr; 48(2):527-36. PubMed ID: 26511814
[TBL] [Abstract][Full Text] [Related]
12. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
Yang W; Lu YP; Yang YZ; Kang JR; Jin YD; Wang HW
J Obstet Gynaecol Res; 2017 Oct; 43(10):1602-1612. PubMed ID: 28833798
[TBL] [Abstract][Full Text] [Related]
13. Association between PD-L1 and HPV status and the prognostic value for HPV treatment in premalignant cervical lesion patients.
Yang-Chun F; Zhen-Zhen C; Yan-Chun H; Xiu-Min M
Medicine (Baltimore); 2017 Jun; 96(25):e7270. PubMed ID: 28640134
[TBL] [Abstract][Full Text] [Related]
14. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.
Thompson ED; Zahurak M; Murphy A; Cornish T; Cuka N; Abdelfatah E; Yang S; Duncan M; Ahuja N; Taube JM; Anders RA; Kelly RJ
Gut; 2017 May; 66(5):794-801. PubMed ID: 26801886
[TBL] [Abstract][Full Text] [Related]
15. Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas.
Reddy OL; Shintaku PI; Moatamed NA
Diagn Pathol; 2017 Jun; 12(1):45. PubMed ID: 28623908
[TBL] [Abstract][Full Text] [Related]
16. PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer.
Saglam O; Conejo-Garcia J
Integr Cancer Sci Ther; 2018; 5(2):. PubMed ID: 29955379
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
18. Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells.
Chen Z; Pang N; Du R; Zhu Y; Fan L; Cai D; Ding Y; Ding J
Mediators Inflamm; 2016; 2016():6891482. PubMed ID: 27721577
[TBL] [Abstract][Full Text] [Related]
19. Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer.
Enwere EK; Kornaga EN; Dean M; Koulis TA; Phan T; Kalantarian M; Köbel M; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
Mod Pathol; 2017 Apr; 30(4):577-586. PubMed ID: 28059093
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
